Evidence mapPaperPMID 39145823Full record

ReviewCell biochemistry and biophysics2025

Therapeutic Targeting of Pattern Recognition Receptors to Modulate Inflammation in Atherosclerosis.

Hongyan Su, Xiancheng Wang, Lu Wang, Na Yuan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cell biochemistry and biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hongyan SuCardiology Department, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130000, China.
Xiancheng WangCardiology Department, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130000, China.
Lu WangCardiology Department, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130000, China.
Na YuanRheumatology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 30000, China. 15164364217@163.com.ORCID http://orcid.org/0009-0004-2594-2472

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis (AS), a potentially fatal cardiovascular disease (CVD), is a chronic inflammatory condition. The disease's onset and progression are influenced by inflammatory and immunological mechanisms. The innate immune pathways are essential in the progression of AS, as they are responsible for detecting first danger signals and causing long-term changes in immune cells. The innate immune system possesses distinct receptors known as pattern recognition receptors (PRRs) which can identify both pathogen-associated molecular patterns and danger-associated molecular signals. Activation of PRRs initiates the inflammatory response in various physiological systems, such as the cardiovascular system. This review specifically examines the contribution of the innate immune response and PRRs to the formation and advancement of AS. Studying the role of these particular receptors in AS would enhance our understanding of the development of AS and offer novel approaches for directly improving the inflammatory response associated with it.

Indexed as

AtherosclerosisInflammationReceptors, Pattern RecognitionAnimalsHumansImmunity, InnateReceptors, Pattern RecognitionAtherosclerosisCardiovascular diseasesPattern recognition receptorToll-like receptor

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.